Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis
about
Stressed Liver and Muscle Call on Adipocytes with FGF21Vitamin E and nonalcoholic fatty liver diseaseThe Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD)S-adenosylmethionine in liver health, injury, and cancer.Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective.Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategiesCirculating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.Mouse betaine-homocysteine S-methyltransferase deficiency reduces body fat via increasing energy expenditure and impairing lipid synthesis and enhancing glucose oxidation in white adipose tissuePersistent organic pollutants and non-alcoholic fatty liver disease in morbidly obese patients: a cohort study.Simple steatosis sensitizes cholestatic rats to liver injury and dysregulates bile salt synthesis and transport.Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus.Clinical implications of understanding the association between oxidative stress and pediatric NAFLD.The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease.1,8-Cineole Ameliorates Steatosis of Pten Liver Specific KO Mice via Akt Inactivation.Control of lipid metabolism by adipocyte FGFR1-mediated adipohepatic communication during hepatic stress.New medical treatment strategies for nonalcoholic steatohepatitis.Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.Resveratrol improves high-fat diet induced fatty liver and insulin resistance by concomitantly inhibiting proteolytic cleavage of sterol regulatory element-binding proteins, free fatty acid oxidation, and intestinal triglyceride absorption.Osteopontin regulates the cross-talk between phosphatidylcholine and cholesterol metabolism in mouse liver.Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans.Dietary conjugated linoleic acid affects blood parameters, liver morphology and expression of selected hepatic genes in laying hens.
P2860
Q27014973-FE64C91E-31EE-404C-8E6A-BE210A108A23Q27693883-7A64ADD2-C1E9-4FC9-BE87-EDF0DE3A6819Q33760717-AE99A052-F2A0-4592-A9FA-BA4DF950C2F8Q34306534-D1713B0B-1499-4747-8B56-32DDC751FA36Q34412650-3C74A95F-F380-40AC-A4EB-8F618E9170ACQ34657286-ED6051B8-0BD1-4C02-B0AB-1A6057AD59ADQ35788887-DA69795F-C121-40ED-8F77-B625A7CF3A15Q35956425-8FEFDB47-B984-42D0-8F8C-D994DAFE33C2Q36105922-FF27F736-EBB2-4B2A-A28C-C38E31BA48CDQ37184782-04A72B39-D948-4408-965F-DDABA3EE0DB0Q37689828-616335E9-E36C-4D6B-BA27-82E8A8C02760Q38794405-16845824-EAF4-4060-8982-BDC20ECFCD6DQ38978486-05BECD8C-F78C-422B-A00B-C7F5EA8EE6C6Q39262148-2D5AC251-59E3-43E5-8F59-C47ECB757D29Q40897334-220F05B1-B4DA-46E6-997F-1807D1584E2EQ41457298-7E7BCEA1-6996-46CA-B633-B304D2E6D61FQ41873388-E61EBABF-90B5-4B74-98AA-2C3C160622C8Q42175498-9CC4F010-FE8A-45D3-A30E-BEB614E0D7F3Q42703776-8B88FF13-E82B-49A5-A45D-87332F5BB6A9Q44697151-933CD4EC-08A6-40A6-86FF-CE42D95F57B0Q46317478-83172B14-9BD1-478F-86FE-28098A9C58B4Q47812994-3862038A-D2A8-4D70-A9F4-129AC16536E4Q51758740-6DE40022-EF82-4F4A-9095-E89AD13BB1D6Q53001535-B287355A-D675-4813-92B2-DCF362380068
P2860
Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Elevated hepatic fatty acid ox ...... n nonalcoholic steatohepatitis
@ast
Elevated hepatic fatty acid ox ...... n nonalcoholic steatohepatitis
@en
type
label
Elevated hepatic fatty acid ox ...... n nonalcoholic steatohepatitis
@ast
Elevated hepatic fatty acid ox ...... n nonalcoholic steatohepatitis
@en
prefLabel
Elevated hepatic fatty acid ox ...... n nonalcoholic steatohepatitis
@ast
Elevated hepatic fatty acid ox ...... n nonalcoholic steatohepatitis
@en
P2093
P2860
P1476
Elevated hepatic fatty acid ox ...... n nonalcoholic steatohepatitis
@en
P2093
Arthur J McCullough
Carole Bennett
Satish C Kalhan
Srinivasan Dasarathy
Susan Marczewski
P2860
P304
P356
10.1097/MEG.0B013E328345C8C7
P577
2011-05-01T00:00:00Z